Pantenol Labesfal (Dexpanthenol)

After application, Dexpanthenol is converted to pantothenic acid within skin cells, contributing to co‑enzyme A production. This enhances fatty acid metabolism, keratinocyte proliferation, and the synthesis of structural lipids, which together speed up epidermal regeneration and improve barrier function.

The dosage of Pantenol Labesfal is determined by the prescribing healthcare professional based on the specific indication, size of the area to be treated, and patient factors. The product is typically applied as a thin layer to the affected skin as directed by the prescriber.

Pregnant or breastfeeding individuals should consult their healthcare provider before using Pantenol Labesfal. While topical Dexpanthenol is generally considered low risk, professional guidance ensures appropriate use and monitoring for any potential concerns.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After submission, the sales team will verify trade or institutional credentials and respond with pricing, availability, shipping details (including cold‑chain if needed), and import documentation.

Compared with other topical agents such as silver sulfadiazine or corticosteroid creams, Pantenol Labesfal offers a vitamin‑based mechanism that promotes natural skin regeneration without the antimicrobial or anti‑inflammatory potency of those alternatives. It is generally well‑tolerated and suitable for mild to moderate skin injuries where barrier restoration is the primary goal.

Store Pantenol Labesfal at room temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Pantenol Labesfal is applied topically to clean, dry skin. A thin, even layer should be spread over the affected area, usually once or twice daily, or as directed by the prescribing clinician. Do not cover with occlusive dressings unless advised.

The most serious risks involve allergic reactions such as contact dermatitis, urticaria, or angioedema. In rare cases, extensive application on large broken skin may lead to systemic absorption and symptoms like nausea or dizziness. Prompt medical attention is required if severe reactions occur.

Individuals with a known hypersensitivity to Dexpanthenol or any component of the formulation should avoid using the product. It is also contraindicated on severely infected wounds without medical supervision and should be used cautiously in pregnant or breastfeeding women without professional advice.